TEXT SIZE a a a
A new case was reported today in a MS patient in the U.S
Posted by Barry Singer, MD on October 29th, filed under Medical Research News.
Alemtuzumab, an antibody therapy, was studied in a Phase II clinical trial.
Posted by Barry Singer, MD on October 26th, filed under Medical Research News.
| ph: 314 872 7333 | 3009 North Ballas - Building B, Suite 207B - St. Louis, Missouri 63131 | MS LivingWell© 2008